Cleared Traditional

K111260 - A/C ENZYMATIC VITAMIN B6 ASSAY

K111260 is an FDA 510(k) clearance for A/C ENZYMATIC VITAMIN B6 ASSAY, manufactured by Anticancer, Inc.. The device is a Class 2 Chemistry device with product code CDD cleared through the Traditional 510(k) pathway after a 448-day FDA review.

K111260 · Anticancer, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2012
Decision
448d
Days
Class 2
Risk

K111260 is an FDA 510(k) clearance for the A/C ENZYMATIC VITAMIN B6 ASSAY. Classified as Radioassay, Vitamin B12 (product code CDD), Class II - Special Controls.

Submitted by Anticancer, Inc. (San Diego, US). The FDA issued a Cleared decision on July 26, 2012 after a review of 448 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1810 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Chemistry submissions.

View all Anticancer, Inc. devices

FDA 510(k) Submission Details - K111260

510(k) Number K111260 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 05, 2011
Decision Date July 26, 2012
Days to Decision 448 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
360d slower than avg
Panel avg: 88d · This submission: 448d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CDD Device Classification - Class 2, Special Controls

Product Code CDD Radioassay, Vitamin B12
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1810
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CDD Radioassay, Vitamin B12

All 67
Devices cleared under the same product code (CDD) and FDA review panel - the closest regulatory comparables to K111260.
LOCI VITAMIN B12 (VB12) FLEX REAGENT CARTRIDGE, LOCI ANEMIA CALIBRATOR (ANEM CAL)
K133512 · Siemens Healthcare Diagnostics · Jan 2014
AXIS-SHIELD ACVTIVE-B12
K121946 · Axis-Shield Diagnostics, Ltd. · Mar 2013
DIMENSION VISTA VITAMIN B12 (VB12) FLEX REAGENT CARTRIDGE, DIMENSION VISTA LOCI 4 CALIBRATOR
K121994 · Siemens Healthcare Diagnostics, Inc. · Nov 2012
ARCHITECT B12
K121314 · Abbott Laboratories · May 2012
ARCHITECT ACTIVE B-12 (HOLOTRANSCOBALAMIN)
K112443 · Axis-Shield Diagnostics, Ltd. · Dec 2011
ARCHITECT B12 REAGENTS, ARCHITECT B12 CALIBRATORS, AND ARCHITECT B12 CONTROLS
K110579 · Abbott Laboratories · Oct 2011